Martin Javier San Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Martin Javier San is Chief Medical Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 198,497 shares of ARWR, which is worth approximately $3.86 Million. The most recent transaction as insider was on Jan 05, 2024, when has been sold 8,303 shares (Common Stock) at a price of $34.93 per share, resulting in proceeds of $290,023. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 198K

0% 3M change

50.6% 12M change

Total Value Held $3.86 Million

Martin Javier San Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2024	SELL Open market or private sale	$290,023 $34.93 p/Share	8,303 Reduced 4.01%	198,497 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	75,000 Added 26.61%	206,800 Common Stock
Nov 20 2023	SELL Open market or private sale	$568,739 $28.87 p/Share	19,700 Reduced 13.0%	131,800 Common Stock
Jan 04 2023	BUY Grant, award, or other acquisition	-	60,000 Added 28.37%	151,500 Common Stock
Nov 21 2022	SELL Open market or private sale	$590,850 $30.3 p/Share	19,500 Reduced 17.57%	91,500 Common Stock
Nov 19 2021	SELL Open market or private sale	$1,365,000 $70.0 p/Share	19,500 Reduced 14.94%	111,000 Common Stock
Nov 19 2020	SELL Open market or private sale	$1,353,105 $69.39 p/Share	19,500 Reduced 13.0%	130,500 Common Stock

Also insider at

ATHA

Athira Pharma, Inc. Healthcare

CHIEF MEDICAL OFFICER

MJS